Hadimioglu Necmiye, Saadawy Iman, Saglam Tayyup, Ertug Zeki, Dinckan Ayhan
Department of Anesthesiology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Anesth Analg. 2008 Jul;107(1):264-9. doi: 10.1213/ane.0b013e3181732d64.
This study aimed to quantify changes in acid-base balance, potassium and lactate levels as a function of administration of different crystalloid solutions during kidney transplantation, and to determine the ideal fluid for such patients.
In this double-blind study, patients were randomized to three groups (n = 30 each) to receive either normal saline, lactated Ringer's, or Plasmalyte, all at 20-30 mL x kg(-1) x h(-1). Arterial blood analyses were performed before induction of anesthesia, and at 30-min intervals during surgery, and total IV fluids recorded. Urine volume, serum creatinine and BUN, and creatinine clearance were recorded on postoperative days 1, 2, 3, and 7.
There was a statistically significant decrease in pH (7.44 +/- 0.50 vs 7.36 +/- 0.05), base excess (0.4 +/- 3.1 vs -4.3 +/- 2.1), and a significant increase in serum chloride (104 +/- 2 vs 125 +/- 3 mM/L) in patients receiving saline during surgery. Lactate levels increased significantly in patients who received Ringer's lactate (0.48 +/- 0.29 vs 1.95 +/- 0.48). No significant changes in acid-base measures or lactate levels occurred in patients who received Plasmalyte. Potassium levels were not significantly changed in any group.
All three crystalloid solutions can be safely used during uncomplicated, short-duration renal transplants; however, the best metabolic profile is maintained in patients who receive Plasmalyte.
本研究旨在量化肾移植过程中不同晶体溶液给药后酸碱平衡、钾和乳酸水平的变化,并确定此类患者的理想液体。
在这项双盲研究中,患者被随机分为三组(每组n = 30),分别接受生理盐水、乳酸林格氏液或Plasmalyte,均以20 - 30 mL×kg⁻¹×h⁻¹的速度输注。在麻醉诱导前、手术期间每隔30分钟进行动脉血分析,并记录总静脉输液量。在术后第1、2、3和7天记录尿量、血清肌酐和尿素氮以及肌酐清除率。
手术期间接受生理盐水的患者pH值(7.44 ± 0.50 vs 7.36 ± 0.05)、碱剩余(0.4 ± 3.1 vs -4.3 ± 2.1)有统计学意义的下降,血清氯显著升高(104 ± 2 vs 125 ± 3 mM/L)。接受乳酸林格氏液的患者乳酸水平显著升高(0.48 ± 0.29 vs 1.95 ± 0.48)。接受Plasmalyte的患者酸碱指标或乳酸水平无显著变化。任何一组的钾水平均无显著变化。
在简单、短期的肾移植手术中,所有三种晶体溶液均可安全使用;然而,接受Plasmalyte的患者维持了最佳的代谢状态。